CS241475B2 - Method of 1,2-bis/(nicotinamido/)-propane preparation - Google Patents

Method of 1,2-bis/(nicotinamido/)-propane preparation Download PDF

Info

Publication number
CS241475B2
CS241475B2 CS807657A CS765780A CS241475B2 CS 241475 B2 CS241475 B2 CS 241475B2 CS 807657 A CS807657 A CS 807657A CS 765780 A CS765780 A CS 765780A CS 241475 B2 CS241475 B2 CS 241475B2
Authority
CS
Czechoslovakia
Prior art keywords
compound
reaction
carried out
bis
acid
Prior art date
Application number
CS807657A
Other languages
Czech (cs)
English (en)
Other versions
CS765780A2 (en
Inventor
Takashi Mori
Sakae Takaku
Fumiaki Matsuura
Yasushi Murakami
Yukifumi Noda
Tamotsu Yamazaki
Tomohiro Neichi
Hiroshi Nakakimura
Shigeyuki Kataoka
Takashi Matsuno
Schun-Chi Hata
Shigeru Takanashi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CS765780A2 publication Critical patent/CS765780A2/cs
Publication of CS241475B2 publication Critical patent/CS241475B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
CS807657A 1979-11-22 1980-11-12 Method of 1,2-bis/(nicotinamido/)-propane preparation CS241475B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15067479A JPS5675474A (en) 1979-11-22 1979-11-22 Nicotinamide derivative and medicine containing the same

Publications (2)

Publication Number Publication Date
CS765780A2 CS765780A2 (en) 1985-07-16
CS241475B2 true CS241475B2 (en) 1986-03-13

Family

ID=15501986

Family Applications (1)

Application Number Title Priority Date Filing Date
CS807657A CS241475B2 (en) 1979-11-22 1980-11-12 Method of 1,2-bis/(nicotinamido/)-propane preparation

Country Status (13)

Country Link
US (1) US4366161A (xx)
EP (1) EP0029602B1 (xx)
JP (1) JPS5675474A (xx)
AR (1) AR229954A1 (xx)
AU (1) AU540216B2 (xx)
CA (1) CA1147732A (xx)
CS (1) CS241475B2 (xx)
DE (1) DE3066874D1 (xx)
DK (1) DK149807C (xx)
ES (1) ES497065A0 (xx)
HU (1) HU180617B (xx)
SU (1) SU1053749A3 (xx)
ZA (1) ZA807283B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
FR2556722B1 (fr) * 1983-12-15 1986-09-26 Merck Clevenot Laboratoires N-valproyl-nicotinamide, procede de preparation et utilisation en therapeutique
ES2061918T3 (es) * 1988-12-27 1994-12-16 Chugai Pharmaceutical Co Ltd Procedimiento para la purificacion de 1,2-bis (nicotinamido) propano.
DE69426295T2 (de) * 1993-05-07 2001-04-05 Chugai Pharmaceutical Co Ltd Organkonservierungsmittel
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
EP1266660A4 (en) * 2000-03-17 2006-03-22 Toshio Tanaka HEME OXYGENASE-1 INDUCTORS OR THEIR PREVENTIVE REINFORCING MEDIUM
AU2001292272A1 (en) * 2000-09-29 2002-04-15 Chugai Seiyaku Kabushiki Kaisha Remedies for brain circulatory disturbances

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392507A (de) * 1960-06-27 1965-05-31 Eprova Ag Verfahren zur Herstellung von Nicotinsäure-aminomethylamiden
FR1335517A (fr) * 1962-03-27 1963-08-23 Ciba Geigy Procédé de préparation d'amides hétérocycliques, notamment de la 3, 3-bis-(4-nicotinoylamino-phényl)-butane-2-one
US3697531A (en) * 1971-02-25 1972-10-10 Sterling Drug Inc N,n{40 -alkylenebis(pyridine-carboxamides)
GB1339764A (en) * 1971-03-29 1973-12-05 Ici Ltd Pyridine derivatives

Also Published As

Publication number Publication date
EP0029602B1 (en) 1984-03-07
ES8203349A1 (es) 1982-04-01
SU1053749A3 (ru) 1983-11-07
DK493780A (da) 1981-05-23
AU6451780A (en) 1981-05-28
AU540216B2 (en) 1984-11-08
DK149807C (da) 1987-03-23
ZA807283B (en) 1981-11-25
AR229954A1 (es) 1984-01-31
US4366161A (en) 1982-12-28
CS765780A2 (en) 1985-07-16
HU180617B (en) 1983-03-28
JPS5675474A (en) 1981-06-22
JPS6155911B2 (xx) 1986-11-29
CA1147732A (en) 1983-06-07
DE3066874D1 (en) 1984-04-12
DK149807B (da) 1986-10-06
EP0029602A1 (en) 1981-06-03
ES497065A0 (es) 1982-04-01

Similar Documents

Publication Publication Date Title
US4225591A (en) 2,6-Diaminonebularines
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
US4299838A (en) Tryptophan derivatives having an increased effect on the central nervous system
US4309427A (en) Benzothiazine dioxide derivatives
NO160778B (no) Analogifremgangsmaate ved fremstilling av nye antifibrinolytisk aktive tranexaminsyreestere.
RU2318811C2 (ru) Амиды антраниловой кислоты, способ их получения и их применение, способ лечения заболевания новообразованием и фармацевтический препарат, обладающий ингибирующей активностью в отношении тирозинкиназного рецептора vegf
RU2174976C2 (ru) N-метил-n-/(1s-)-1-фенил-2-((3s)-3-гидроксипирролидин-1-ил)-этил/-2,2-дифенилацетамид
CS241475B2 (en) Method of 1,2-bis/(nicotinamido/)-propane preparation
NO762778L (xx)
US3931212A (en) Method for treating cardiovascular circulatory insufficiencies and hypotonia with 2-hydroxy-phenyl-1-oxa-4-azaspiroalkane derivatives
US5747521A (en) N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same
US4258033A (en) 2,6-Diaminonebularines
JPH0222271A (ja) 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
CS256397B2 (en) Method of new pyridylmethylthiothieno-(2,3-d)imidazole derivatives production
CZ280129B6 (cs) Diamidy N,N'-bis-/alkoxyalkyl/-pyridin-2,4-dikarboxylové kyseliny, způsob jejich výroby, jejich použití a farmaceutický prostředek tyto látky obsahující
US6071968A (en) Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
US6949656B2 (en) Cyclic amine derivatives and use thereof
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
JPS6197284A (ja) ピリジルフエニルピリダジノン変力剤
JPH0211592A (ja) 光学活性なジヒドロピリジンホスホン酸エステル
JPH03218361A (ja) ９―アシルアミノテトラヒドロアクリジン誘導体
KR840001559B1 (ko) 니코틴 아미드 유도체의 제조방법
US4000306A (en) Anti-arrhythmic compositions containing isoindoline derivatives
BE877510Q (fr) Nouveaux esters du 1-(p-hydroxy-phenyl)-2-(1'-methyl-2'-phenoxyethylamino)-1-propanol, leur application en therapeutique et leur procede de preparation
CA2070651A1 (en) Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use